Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells
Open Access
- 25 October 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 88 (4), 566-574
- https://doi.org/10.1002/1097-0215(20001115)88:4<566::aid-ijc8>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathwayOncogene, 1999
- Proteolytic processing of the adherens junctions components β-catenin and γ-catenin/plakoglobin during apoptosisCell Death & Differentiation, 1998
- Inhibition of Human Squamous Cell Carcinoma Growth In Vivo by Epidermal Growth Factor Receptor Antisense RNA Transcribed From the U6 PromoterJNCI Journal of the National Cancer Institute, 1998
- Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptorsThe EMBO Journal, 1997
- Control of adhesion-dependent cell survival by focal adhesion kinase.The Journal of cell biology, 1996
- Cadherin-catenin complex: Protein interactions and their implications for cadherin functionJournal of Cellular Biochemistry, 1996
- mRNA phenotyping of the major ligands and receptors of the EGF supergene family in human ovarian epithelial cellsCancer Letters, 1995
- Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene.Proceedings of the National Academy of Sciences, 1994
- The EGF receptor is an actin-binding protein.The Journal of cell biology, 1992
- The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1989